Insiders · MAIA

Stan Smith

Director at MAIA Biotechnology, Inc. (MAIA)

Stan Smith has filed 50 insider reports with the SEC since August 2022, as director at MAIA Biotechnology, Inc. (MAIA). In the last 12 months Stan Smith bought $237K of stock on the open market. The latest filing, on October 2, 2026, reports grant or award at MAIA Biotechnology, Inc. (MAIA).

Filings
50
Companies
1
Bought on market
$2.86M
Sold on market
None

Companies where Stan Smith is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
MAIA Biotechnology, Inc. logo
MAIA
MAIA Biotechnology, Inc.
Director$2.86M$2.28$1.01-56%Oct 2, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Stan Smith with

Other insiders at the same companies

Questions about Stan Smith

What is Stan Smith's role at MAIA Biotechnology, Inc.?
Stan Smith reports to the SEC as director at MAIA Biotechnology, Inc. (MAIA), according to the latest filing on October 2, 2026.
Has Stan Smith bought or sold stock recently?
The most recent open-market purchase was on June 1, 2026: bought 75,000 shares of MAIA Biotechnology, Inc. (MAIA) for $100K at an average of $1.34.
How do I get alerts when Stan Smith files?
Follow Stan Smith on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Stan Smith filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Stan Smith (SEC CIK 0001913199). Totals count each trade once, skipping amendments whose original is on file, from Aug 2, 2022 on. View on SEC EDGAR